$17.5K up for grabs in online blockchain hackathon with COVID in its sights

Dave Pearson | | Health Exec | Artificial Intelligence
Blockchain

A blockchain startup headquartered in the British Virgin Islands is organizing a global, healthcare-specific online hackathon with a prize pool of 15,000 euros, or around $17,500.

The company, Maxonrow, says successful contestants will apply blockchain solutions to five specific challenges, all geared at innovating responses to COVID-19 and future pandemics.

The event will start on Sept. 5 and run till Oct. 3.

The challenges will involve contact tracing, issuing health and vaccine certifications, welfare, social networking and data analytics, according to an announcement.

To register or learn more about the hackathon, click here.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Advancing AI for vascular surgery will require a commitment to data integrity
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy
Healthcare AI regulation needs nuance, balance: Research review
New AI program delivers rapid, accurate echo video assessments
ICU diary-keeping: There’s an AI for that
FDA commissioner urges health systems to strengthen AI quality oversight

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.